Eintrag weiter verarbeiten
Attainment and Maintenance of Platelet Inhibition Through Standard Dosing of Abciximab in Patients Undergoing Percutaneous Coronary Intervention
Gespeichert in:
| Zeitschriftentitel: | Circulation |
|---|---|
| Personen und Körperschaften: | |
| In: | Circulation, 102, 2000, 25 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Ovid Technologies (Wolters Kluwer Health)
|
| Schlagwörter: |
| author_facet |
Kereiakes, Dean J. Kereiakes, Dean J. |
|---|---|
| author |
Kereiakes, Dean J. |
| spellingShingle |
Kereiakes, Dean J. Circulation Attainment and Maintenance of Platelet Inhibition Through Standard Dosing of Abciximab in Patients Undergoing Percutaneous Coronary Intervention Physiology (medical) Cardiology and Cardiovascular Medicine |
| author_sort |
kereiakes, dean j. |
| spelling |
Kereiakes, Dean J. 0009-7322 1524-4539 Ovid Technologies (Wolters Kluwer Health) Physiology (medical) Cardiology and Cardiovascular Medicine http://dx.doi.org/10.1161/01.cir.102.25.e186 Attainment and Maintenance of Platelet Inhibition Through Standard Dosing of Abciximab in Patients Undergoing Percutaneous Coronary Intervention Circulation |
| doi_str_mv |
10.1161/01.cir.102.25.e186 |
| facet_avail |
Online Free |
| finc_class_facet |
Biologie Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE2MS8wMS5jaXIuMTAyLjI1LmUxODY |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE2MS8wMS5jaXIuMTAyLjI1LmUxODY |
| institution |
DE-15 DE-Rs1 DE-Pl11 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 |
| imprint |
Ovid Technologies (Wolters Kluwer Health), 2000 |
| imprint_str_mv |
Ovid Technologies (Wolters Kluwer Health), 2000 |
| issn |
0009-7322 1524-4539 |
| issn_str_mv |
0009-7322 1524-4539 |
| language |
English |
| mega_collection |
Ovid Technologies (Wolters Kluwer Health) (CrossRef) |
| match_str |
kereiakes2000attainmentandmaintenanceofplateletinhibitionthroughstandarddosingofabciximabinpatientsundergoingpercutaneouscoronaryintervention |
| publishDateSort |
2000 |
| publisher |
Ovid Technologies (Wolters Kluwer Health) |
| recordtype |
ai |
| record_format |
ai |
| series |
Circulation |
| source_id |
49 |
| title |
Attainment and Maintenance of Platelet Inhibition Through Standard Dosing of Abciximab in Patients Undergoing Percutaneous Coronary Intervention |
| title_unstemmed |
Attainment and Maintenance of Platelet Inhibition Through Standard Dosing of Abciximab in Patients Undergoing Percutaneous Coronary Intervention |
| title_full |
Attainment and Maintenance of Platelet Inhibition Through Standard Dosing of Abciximab in Patients Undergoing Percutaneous Coronary Intervention |
| title_fullStr |
Attainment and Maintenance of Platelet Inhibition Through Standard Dosing of Abciximab in Patients Undergoing Percutaneous Coronary Intervention |
| title_full_unstemmed |
Attainment and Maintenance of Platelet Inhibition Through Standard Dosing of Abciximab in Patients Undergoing Percutaneous Coronary Intervention |
| title_short |
Attainment and Maintenance of Platelet Inhibition Through Standard Dosing of Abciximab in Patients Undergoing Percutaneous Coronary Intervention |
| title_sort |
attainment and maintenance of platelet inhibition through standard dosing of abciximab in patients undergoing percutaneous coronary intervention |
| topic |
Physiology (medical) Cardiology and Cardiovascular Medicine |
| url |
http://dx.doi.org/10.1161/01.cir.102.25.e186 |
| publishDate |
2000 |
| physical |
|
| description |
|
| container_issue |
25 |
| container_start_page |
0 |
| container_title |
Circulation |
| container_volume |
102 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792338953258401796 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T15:40:02.628Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Attainment+and+Maintenance+of+Platelet+Inhibition+Through+Standard+Dosing+of+Abciximab+in+Patients+Undergoing+Percutaneous+Coronary+Intervention&rft.date=2000-12-19&genre=article&issn=1524-4539&volume=102&issue=25&jtitle=Circulation&atitle=Attainment+and+Maintenance+of+Platelet+Inhibition+Through+Standard+Dosing+of+Abciximab+in+Patients+Undergoing+Percutaneous+Coronary+Intervention&aulast=Kereiakes&aufirst=Dean+J.&rft_id=info%3Adoi%2F10.1161%2F01.cir.102.25.e186&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792338953258401796 |
| author | Kereiakes, Dean J. |
| author_facet | Kereiakes, Dean J., Kereiakes, Dean J. |
| author_sort | kereiakes, dean j. |
| container_issue | 25 |
| container_start_page | 0 |
| container_title | Circulation |
| container_volume | 102 |
| description | |
| doi_str_mv | 10.1161/01.cir.102.25.e186 |
| facet_avail | Online, Free |
| finc_class_facet | Biologie, Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE2MS8wMS5jaXIuMTAyLjI1LmUxODY |
| imprint | Ovid Technologies (Wolters Kluwer Health), 2000 |
| imprint_str_mv | Ovid Technologies (Wolters Kluwer Health), 2000 |
| institution | DE-15, DE-Rs1, DE-Pl11, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4 |
| issn | 0009-7322, 1524-4539 |
| issn_str_mv | 0009-7322, 1524-4539 |
| language | English |
| last_indexed | 2024-03-01T15:40:02.628Z |
| match_str | kereiakes2000attainmentandmaintenanceofplateletinhibitionthroughstandarddosingofabciximabinpatientsundergoingpercutaneouscoronaryintervention |
| mega_collection | Ovid Technologies (Wolters Kluwer Health) (CrossRef) |
| physical | |
| publishDate | 2000 |
| publishDateSort | 2000 |
| publisher | Ovid Technologies (Wolters Kluwer Health) |
| record_format | ai |
| recordtype | ai |
| series | Circulation |
| source_id | 49 |
| spelling | Kereiakes, Dean J. 0009-7322 1524-4539 Ovid Technologies (Wolters Kluwer Health) Physiology (medical) Cardiology and Cardiovascular Medicine http://dx.doi.org/10.1161/01.cir.102.25.e186 Attainment and Maintenance of Platelet Inhibition Through Standard Dosing of Abciximab in Patients Undergoing Percutaneous Coronary Intervention Circulation |
| spellingShingle | Kereiakes, Dean J., Circulation, Attainment and Maintenance of Platelet Inhibition Through Standard Dosing of Abciximab in Patients Undergoing Percutaneous Coronary Intervention, Physiology (medical), Cardiology and Cardiovascular Medicine |
| title | Attainment and Maintenance of Platelet Inhibition Through Standard Dosing of Abciximab in Patients Undergoing Percutaneous Coronary Intervention |
| title_full | Attainment and Maintenance of Platelet Inhibition Through Standard Dosing of Abciximab in Patients Undergoing Percutaneous Coronary Intervention |
| title_fullStr | Attainment and Maintenance of Platelet Inhibition Through Standard Dosing of Abciximab in Patients Undergoing Percutaneous Coronary Intervention |
| title_full_unstemmed | Attainment and Maintenance of Platelet Inhibition Through Standard Dosing of Abciximab in Patients Undergoing Percutaneous Coronary Intervention |
| title_short | Attainment and Maintenance of Platelet Inhibition Through Standard Dosing of Abciximab in Patients Undergoing Percutaneous Coronary Intervention |
| title_sort | attainment and maintenance of platelet inhibition through standard dosing of abciximab in patients undergoing percutaneous coronary intervention |
| title_unstemmed | Attainment and Maintenance of Platelet Inhibition Through Standard Dosing of Abciximab in Patients Undergoing Percutaneous Coronary Intervention |
| topic | Physiology (medical), Cardiology and Cardiovascular Medicine |
| url | http://dx.doi.org/10.1161/01.cir.102.25.e186 |